Severe COVID-19 patients present a “cytokine storm” with cytokine release of interleukins, such as IL-1, IL-6, tumor necrosis factor (TNFa), and other inflammatory mediators, leading to a pulmonary inflammatory response making oxygenation challenging [60,61]. This evidence concerns the gene TNF and COVID-19.